biosink notebook: "Pharma Marketing Blog: Why Grow Your Own Drugs When You Can Buy Them Off the Street?
pharmamkting.blogspot.com/2007/07/why-grow-your-ow...
I've argued that the $1 Billion number is based less on actual costs than on a Tufts' analysis, which includes about $400 million in 'lost opportunity' costs (see 'Tufts Hangs Tough on Opportunity Cost Analysis')."
